Knowledge center

Request audit Contact us

New Q&A on the obligation to inform in case of interruption or discontinuation of supply

Solutions

Pharma & Biotech

⌞ Market Entry into the EU
⌞ Emerging Biotech
⌞ Manufacturing Quality & Compliance

Medical Devices & IVD

⌞ Market Entry into the EU
⌞ Emerging MedTech
⌞ Software as a Medical Device

Cross-Industry

⌞ Life Cycle Management

Industries

Pharma & Biotech
Medical Devices
In Vitro Diagnostics
Companion Diagnostics (CDx)
Combination Products
SaMD / Medical Device Software

Services

⌞ Audits
⌞ Clinical
⌞ Lab Services
⌞ Pharmacovigilance
⌞ Qualification & Validation
⌞ Quality Assurance
⌞ Regulatory Affairs
⌞ Software Solutions & Services
⌞ Toxicology

Knowledge center

⌞ Downloads
⌞ Blogs
⌞ Webinars
⌞ Case studies
⌞ Regulatory updates
⌞ Company news

About Us

⌞ About us
⌞ Our story
⌞ Team
⌞ Board of Advisors
⌞ Ecosystem
⌞ Projects
⌞ QbD Group Foundation
⌞ Careers
⌞ Contact us

Certifications

⌞ ISO 13485:2016
⌞ ISO/IEC 27001:2022
⌞ GMDP license
⌞ EUROTOX

Newsletter

Stay up to date with the latest in life sciences. Get tailored industry news delivered straight to your inbox.

QbD Group WeChat QR Code

Scan to follow on WeChat

+32 (0)3 844 45 01 QbD Group. Groenenborgerlaan 16, 2610 Wilrijk, BelgiumVAT: BE0795 392 179

Cookie Statement|Privacy policy|Terms & Conditions|Supplier Code of Conduct|Sitemap

Report an issue|© 2026 QbD Group. All rights reserved.